YUMAB The success of next genera-tion antibody drug development relieson comprehensive discovery technolo-gies and strategies.

YUMAB bridges the gap between re-search innovation and novel therapies.Our advanced discovery platform provi-des access to challenging targets, enablesnew formats, and accelerates the deve-lopment of human antibodies at a highsuccess rate.

From target discovery to fully characte-rised lead – our experienced team leadsbiotech and pharma teams worldwidethrough the development process asyour trusted, de-risking partner.

 

Antibody Discovery

• Advanced discovery platform for nextgeneration biotherapeutics.
• Access to challenging targets and newformats for drug discovery at highspeed and success rate.
• Fully integrated human antibody deve-lopment in one company – tailored toyour needs.
• Optimized discovery solution usingantigen-positive cells as a target duringselection.

Antibody Libraries

• Universal human antibody librarieswith more than 100 billion (1011) uniqueantibodies.
• Highly productive pre-selected antibo-dy sequences.
• Large epitope coverage and high hit rate.
• Flexible business conditions.

Antibody Engineering

• YUMAB® platform can be used for theengineering of externally generatedalready existing antibodies.
• Two in-vitro evolution technologies.